While overall HF incidence is declining among Medicare beneficiaries with primary risk factors, the rising incidence in patients with acute MI and atrial fibrillation identifies key targets for future prevention strategies.
Answers are grounded in this paper and cite their sources.
Rising HF incidence post-MI and AF identifies prevention targets; hypothesis-generating for targeted trials.
Findings of this study suggest that the temporal decline in HF incidence among Medicare beneficiaries reflects a decrease in HF incidence among those with primary HF risk factors. The increase in HF incidence among those with acute MI and those with AF highlights potential targets for future HF prevention strategies.
No takes yet. Share an insight, caveat, or question.
Khera et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: